In 2023, the bread improvers market is anticipated to be worth USD 4.4 billion. The bread improvers market is anticipated to ...

As of now, Galmed Pharmaceuticals has shown a remarkable year-to-date performance of +85.14%. In comparison, the S&P 500 has returned +19.90% over the same period. This stark contrast highlights ...

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for fibroinflammatory indications announced today that based on the recently ...

Some chocolate pudding pots contain a lot of sodium. Yes, really. But there's one brand mindful of those who are looking to ...